Frost & Sullivan Release: Gamma Cameras To Remain Stable And PET To Decline In European Nuclear Medical Imaging Markets

LONDON, April 26 /PRNewswire/ -- The introduction of new technologies is set to revitalise the increasingly mature European nuclear medical imaging markets. Despite relative stability, innovative and enhanced imaging techniques such as SPECT will energise the saturated gamma camera segment. Moreover, PET-CT scanners will rapidly replace existing PET systems, resulting in revenue attenuation.

Frost & Sullivan (http://www.healthcare.frost.com) finds that the European Nuclear Medicine Imaging Systems Markets earned revenues of US$155.7 million in 2005 and estimates to reach US$138.9 million in 2010.

“Increased attention towards molecular imaging will be one of the key drivers for the nuclear medicine market,” notes Frost & Sullivan Industry Analyst, Srividya Badrinarayanan. “As R&D focus shifts towards molecular imaging, the advancements in and the presence of imaging modalities for nuclear imaging would be very essential for its growth.”

Molecular imaging is now considered the technology of the future as it provides detailed information about diseases and methods to treat them. This will promote the uptake of advanced technologies in nuclear medicine imaging.

Saturation in the gamma market can be overcome only through the introduction of new applications. In the case of the PET scanners market, the availability of its radioisotopes will generate additional interest among end users.

“Constant technological innovation is one of the key factors for the growth of this market,” says Ms. Badrinarayanan. “Companies need to continually develop and introduce new technologies as well as expand clinical applications for the present one - all of which requires increased R&D efforts and a focus on evolving customer preferences.”

To sustain their profitability, market vendors need to design appropriate pricing plans for their systems and create more awareness on the advantages of new technologies and applications. Also, an adequate focus on partnering with radiopharmaceuticals companies will help market participants offer comprehensive solutions to customers.

Nuclear Medicine Imaging Systems Markets in Europe is part of the Diagnostic Imaging Subscription, which also includes research in the following markets: World Global Gamma Camera Market and US PET and PET-CT Markets. All research included in subscriptions provide detailed market opportunities and industry trends. All research is evaluated following extensive interviews with market participants. Interviews are available to the press.

If you are interested in a virtual brochure, which provides manufacturers, end users, and other industry participants with an overview of the latest analysis of the Nuclear Medicine Imaging Systems Markets in Europe then send an e-mail to Radhika Menon Theodore- Corporate Communications at rmtheodore@frost.com with the following information: your full name, company name, title, telephone number, e-mail address, city, state, and country. We will send you the information via email upon receipt of the above information.

Frost & Sullivan, a global growth consulting company, has been partnering with clients to support the development of innovative strategies for more than 40 years. The company’s industry expertise integrates growth consulting, growth partnership services and corporate management training to identify and develop opportunities. Frost & Sullivan serves an extensive clientele that includes Global 1000 companies, emerging companies, and the investment community by providing comprehensive industry coverage that reflects a unique global perspective and combines ongoing analysis of markets, technologies, econometrics, and demographics. For more information, visit www.frost.com.

Nuclear Medicine Imaging Systems Markets in Europe B693-50 Contact: Radhika Menon Theodore Corporate Communications - Europe P: +91-44-42044541 F: +91-44-24314264 E: rmtheodore@frost.com Melina Trevino Corporate Communications - Americas P: +1-210-247-2440 F: +1-210-348-1003 E: melina.trevino@frost.com Surbhi Dedhia Corporate Communications - India P: +91-22-2832-4705 Ext: 131 E: sdedhia@frost.com Jasminder Kaur Corporate Communications - Asia Pacific P: +65-68900937 E: jkaur@frost.com Sharmin Jassal Corporate Communications - Australia P: +61-2-8247-8900 F: +61-2-9252-8066 E: sjassal@frost.comwww.frost.com

List of keywords: nuclear medicine, Europe, SPECT, PET-CT scanners, PET scanners, nuclear medicine imaging systems, molecular imaging, imaging modalities, nuclear imaging, radioisotopes

List of key market participants: GE Healthcare, Siemens Medical Solutions, Philips Medical Solutions, Gamma Medica, Positron Corporation

Frost & Sullivan

CONTACT: Radhika Menon Theodore, Corporate Communications - Europe, Tel:+91-44-42044541, F: +91-44-24314264, E: rmtheodore@frost.com, MelinaTrevino, Corporate Communications - Americas, Tel: +1-210-247-2440, F:+1-210-348-1003, E: melina.trevino@frost.com, Surbhi Dedhia, CorporateCommunications - India, Tel: +91-22-2832-4705 Ext: 131, E:sdedhia@frost.com, Jasminder Kaur, Corporate Communications - Asia Pacific:Tel: +65-68900937, E: jkaur@frost.com, Sharmin Jassal, CorporateCommunications - Australia, Tel: +61-2-8247-8900, F: +61-2-9252-8066, E:sjassal@frost.com

MORE ON THIS TOPIC